SEC Filing | Stereotaxis Inc.

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lele Abhijeet J

(Last)

(First)

(Middle)

C/O EP MEDYSTEMS

575 RTE 73 N

(Street)

WEST BERLIN

08091

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/11/2004

3. Issuer Name and Ticker or Trading Symbol
Stereotaxis, Inc. [ STXS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	05/26/2005	05/26/2014	Common Stock	8,333	7.02	D
Series D Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	41,694	⁽²⁾	I	EGS Private Healthcare Counterpart, L.P.
Series D Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	291,863	⁽²⁾	I	EGS Private Healthcare Partnership, L.P.
Series D-1 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	16,001	⁽²⁾	I	EGS Private Healthcare Counterpart, L.P.
Series D-1 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	112,007	⁽²⁾	I	EGS Private Healthcare Partnership, L.P.
Series D-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	72,976	⁽²⁾	I	EGS Private Healthcare Canadian Partners, L.P.
Series D-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	24,001	⁽²⁾	I	EGS Private Healthcare Counterpart, L.P.
Series D-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	76,484	⁽²⁾	I	EGS Private Healthcare Investors, L.P.
Series D-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	484,967	⁽²⁾	I	EGS Private Healthcare Partnership II, L.P.
Series D-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	168,010	⁽²⁾	I	EGS Private Healthcare Partnership, L.P.
Series D-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	5,613	⁽²⁾	I	EGS Private Healthcare President's Fund, L.P.
Series E-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	43,237	⁽²⁾	I	EGS Private Healthcare Canadian Partners, L.P.
Series E-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	45,316	⁽²⁾	I	EGS Private Healthcare Investors II, L.P.
Series E-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	287,338	⁽²⁾	I	EGS Private Healthcare Partnership II, L.P.
Series E-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	3,326	⁽²⁾	I	EGS Private Healthcare President's Fund, L.P.
Series D-1 Common Stock Warrants	11/21/2001	11/21/2006	Common Stock	2,400	7.81	I	EGS Private Healthcare Counterpart, L.P.
Series D-1 Common Stock Warrants	11/21/2001	11/21/2006	Common Stock	16,800	7.81	I	EGS Private Healthcare Partnership, L.P.
Series D-2 Common Stock Warrants	12/17/2002	12/31/2007	Common Stock	3,600	7.81	I	EGS Private Healthcare Counterpart, L.P.
Series D-2 Common Stock Warrants	12/17/2002	12/31/2007	Common Stock	25,201	7.81	I	EGS Private Healthcare Partnership, L.P.
Series D-2 Common Stock Warrants	01/21/2003	12/31/2007	Common Stock	10,946	7.81	I	EGS Private Healthcare Canadian Partners, L.P.
Series D-2 Common Stock Warrants	01/21/2003	12/31/2007	Common Stock	11,472	7.81	I	EGS Private Healthcare Investors II, L.P.
Series D-2 Common Stock Warrants	01/21/2003	12/31/2007	Common Stock	72,745	7.81	I	EGS Private Healthcare Partnership II, L.P.
Series D-2 Common Stock Warrants	01/21/2003	12/31/2007	Common Stock	841	7.81	I	EGS Private Healthcare President's Fund, L.P.
Series E-2 Common Stock Warrants	01/28/2004	01/27/2009	Common Stock	8,647	10.55	I	EGS Private Healthcare Canadian Partners, L.P.
Series E-2 Common Stock Warrants	01/28/2004	01/27/2009	Common Stock	9,063	10.55	I	EGS Private Healthcare Investors II, L.P.
Series E-2 Common Stock Warrants	01/28/2004	01/27/2009	Common Stock	57,467	10.55	I	EGS Private Healthcare Partnership II, L.P.
Series E-2 Common Stock Warrants	01/28/2004	01/27/2009	Common Stock	655	10.55	I	EGS Private Healthcare President's Fund, L.P.

Explanation of Responses:

1. All Series of the Issuer's Convertible Preferred Stock are convertible into common stock upon demand at any time.

2. 1-for-3.6.

	/s/ Abhijeet J. Lele	08/04/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Innovation Day